Antibiotic resistance and therapeutic options in lower respiratory tract infections

International Journal of Antimicrobial Agents

Volumn 11, Issue SUPPL. 1, 1999, Pages S3-

  Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Community acquired pneumonia; Macrolides; Resistance; Therapy; Lactams

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; ERYTHROMYCIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; CONFERENCE PAPER; DRUG CHOICE; HUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0032934711     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00097-1     Document Type: Conference Paper

References (32)

1. Advanced Report of Final Mortality Statistics. v. 42. National Center of Health Statistics, 1992.
2. Donowitz G.R., Mandell G.L. Acute pneumonia. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 4th edn:1995;619-637 Churchill Livingstone, New York.
3. Sherman M.M., Subramanian V., Berger R.L. Management of thoracic empyema. Am. J. Surg. 133:1977;474-479.
4. Bryant R.E. Pleural effusion and empyema. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 4th edn. 1995;637-641 Churchill Livingstone, New York.
5. Grayston J.T., Diwan V.K., Cooney M. et al. Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch. Intern. Med. 149:1989;169-173.
6. Grayston J.T., Kuo C.C., Wang S.P. et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. N Engl. J. Med. 315:1986;161-168.
7. Marrie T.J., Grayston J.T., Wang S.P. et al. Pneumonia associated with the TWAR strain of Chlamydia. Ann. Intern. Med. 106:1987;507-511.
8. Thom D.H., Grayston J.T. Infections with Chlamydia pneumoniae strain TWAR. Clin. Chest. Med. 12:1991;245-256.
9. Marrie T.J. Coxiella burnetii (Q Fever). Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 4th edn:1995;1727-1735 Churchill Livingstone, New York.
10. Rylander M, Hallander HO. In vitro comparison of the activity of doycycline, tetracycline, erythromycin and a new macrolide, CP-62,993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis Suppl 1988;53: 12-7.
11. Chirgwin K., Roblin P.M., Hammerschlag M.R. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob Agents Chemother. 33:1989;1634-1635.
12. Dunkin K.T., Jones S., Howard A.J. The in vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci. J. Antimicrob. Chemother. 21:1988;405-411.
13. Baquero F. Epidemiology and management of penicillin-resistant pneumococci. Curr. Opin. Infect. Dis. 9:1996;372-379.
14. Coffey T.J., Dowson C.G., Daniels M., Spratt B.G. Horizontal spread of an altered penicillin-binding protein 2B gene between Streptococcus pneumoniae and Streptococcus oralis. FEMS Microbiol. Lett. 110:1993;335-339.
15. Doern G.V., Ferraro M.J., Brueggemann A.B., Ruoff K.L. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:1996;891-894.
16. Mogi A., Nishi J.I., Yoshinaga M. et al. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by β-lactam agents and in those with oncohematologic diseases. Pediatr. Infect. Dis. J. 16:1997;1140-1144.
17. Wu J.J., Lin K.Y., Hsueh P.R., Liu J.W., Pan H.I., Sheu S.M. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:1997;844-846.
18. Potgieter E., Carmichael M., Koornhof H.J., Chalkley L.J. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;543-546.
19. Pradier C., Dunais B., Carsenti-Etesse H., Dellamonica P. Pneumococcal resistance patterns in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 16:1997;644-647.
20. Alcaide F., Liñares J., Pallares R. et al. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob. Agents. Chemother. 39:1995;2243-2247.
21. Pallares R., Liñares J., Vadillo M. et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:1995;474-480.
22. Sandford JP, Gilbert DN, Sande MA. Guide to antimicrobial therapy, 26th edn. Dallas, Antimicrobial therapy Inc., 1996.
23. Baquero F, Garcia Rodriguez JA, Garcia de Lomas J, Bouza E. Antimicrobial resistance of Streptococcus pneumoniae isolates from respiratory tract infections in Spain. Results of a 1-year (1996-97) multicenter surveillance study. Antimicrob Agents Chemother, 1998 (in press).
24. Torres L, Pelaez T, Vasallo FJ, et al. Evolution of antibiotic resistance of Streptococcus pneumoniae: Increase of penicillin resistance in blood and CSF isolates. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28-October 1 1997. (Abstract no. C-168).
25. Garau J, Bouza E, 1998 (in press).
26. Johnson C.C., Tunkel A.R. Viridans streptococci and groups C and G streptococci. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 4th edn:1995;1845-1861 Churchill Livingstone, New York.
27. Bouza E, et al. Resistencia de estreptococcos del grupe viridans en los aisiados de un Hospital General. VIII Congreso Sociedad Española de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC). Palma de Mallorca. May, 1998.
28. Alcaide F., Carratala J., Liñares J., Gudiol F., Martin R. In vitro activity of eight macrolide antibiotics and RP-59500 (quinupristin-dafopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob. Agents Chemother. 40:1996;2117-2120.
29. Pascual-Velasco F., Montes M., Marimon J.M., Cilla G. High seroprevalence of Coxiella burnetii infection in Eastern Cantabria (Spain). Int. J. Epidemiol. 27:1998;142-145.
30. Sobradillo V., Ansola P., Baranda F., Corral C. Q fever pneumonia: a review of 164 community-acquired cases in the Basque country. Eur. Respir. J. 2:1989;263-266.
31. Turck W.P.G. Q fever. Braude A.L., Davis C.E., Fierer J. Medical Microbiology and Infectious Diseases. 1981;932-937 WB Saunders, Philadelphia.
32. Maurin M., Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents. Chemother. 37:1993;2633-2637.